Boston Scientific Net Income 2006-2018 | BSX

Boston Scientific annual/quarterly net income history and growth rate from 2006 to 2018. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • Boston Scientific net income for the quarter ending September 30, 2018 was $0.432B, a 52.65% increase year-over-year.
  • Boston Scientific net income for the twelve months ending September 30, 2018 was $670M, a 20.52% decline year-over-year.
  • Boston Scientific annual net income for 2017 was $0.104B, a 70.03% decline from 2016.
  • Boston Scientific annual net income for 2016 was $0.347B, a 245.19% decline from 2015.
  • Boston Scientific annual net income for 2015 was $-0.239B, a 100.84% increase from 2014.
Boston Scientific Annual Net Income
(Millions of US $)
2017 $104
2016 $347
2015 $-239
2014 $-119
2013 $-121
2012 $-4,068
2011 $441
2010 $-1,065
2009 $-1,025
2008 $-2,036
2007 $-495
2006 $-3,577
2005 $628
Boston Scientific Quarterly Net Income
(Millions of US $)
Q3 2018 $432
Q2 2018 $555
Q1 2018 $298
Q4 2017 $-615
Q3 2017 $283
Q2 2017 $146
Q1 2017 $290
Q4 2016 $124
Q3 2016 $228
Q2 2016 $-207
Q1 2016 $202
Q4 2015 $-142
Q3 2015 $-198
Q2 2015 $102
Q1 2015 $-1
Q4 2014 $-299
Q3 2014 $43
Q2 2014 $4
Q1 2014 $133
Q4 2013 $108
Q3 2013 $-5
Q2 2013 $130
Q1 2013 $-354
Q4 2012 $61
Q3 2012 $-664
Q2 2012 $-3,578
Q1 2012 $113
Q4 2011 $107
Q3 2011 $142
Q2 2011 $146
Q1 2011 $46
Q4 2010 $236
Q3 2010 $190
Q2 2010 $98
Q1 2010 $-1,589
Q4 2009 $-1,076
Q3 2009 $-94
Q2 2009 $158
Q1 2009 $-13
Q4 2008 $-2,382
Q3 2008 $-74
Q2 2008 $98
Q1 2008 $322
Q4 2007 $-458
Q3 2007 $-272
Q2 2007 $115
Q1 2007 $120
Q4 2006 $277
Q3 2006 $76
Q2 2006 $-4,262
Q1 2006 $332
Q4 2005 $334
Q3 2005 $-269
Q2 2005 $205
Q1 2005 $358
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $50.107B $9.048B
Boston Scientific Corporation transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader they advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $124.396B 19.07
Abbott Laboratories (ABT) United States $121.907B 24.70
Stryker (SYK) United States $62.115B 23.41
Baxter (BAX) United States $33.967B 21.93
Zimmer Biomet Holdings (ZBH) United States $22.913B 14.86
Smith & Nephew SNATS (SNN) United Kingdom $16.016B 0.00
ResMed (RMD) United States $14.484B 27.62
Perrigo (PRGO) Ireland $8.621B 13.09
Bio-Rad Laboratories (BIO) United States $8.038B 51.40
Canopy Growth (CGC) Canada $7.963B 0.00
Hill-Rom Holdings (HRC) United States $6.061B 19.22
Aurora Cannabis (ACB) Canada $5.941B 32.42
Haemonetics (HAE) United States $5.495B 48.32
Hutchison China MediTech (HCM) China $5.011B 0.00
Insulet (PODD) United States $4.690B 0.00
ICU Medical (ICUI) United States $4.600B 25.63
GW Pharmaceuticals (GWPH) United Kingdom $3.898B 0.00
Agios Pharmaceuticals (AGIO) United States $3.709B 0.00
National Vision Holdings (EYE) United States $3.224B 62.36
Neogen (NEOG) United States $3.190B 48.31
NuVasive (NUVA) United States $3.045B 28.33
Quidel (QDEL) United States $2.390B 31.16
Aphria (APHA) $2.383B 0.00
NxStage Medical (NXTM) United States $1.935B 0.00
Phibro Animal Health (PAHC) United States $1.455B 20.60
AtriCure (ATRC) United States $1.189B 0.00
Cardiovascular Systems (CSII) United States $1.007B 1450.50
VAREX IMAGING (VREX) United States $0.933B 18.74
Meridian Bioscience (VIVO) United States $0.816B 26.01
Surmodics (SRDX) United States $0.775B 118.39
OraSure Technologies (OSUR) United States $0.771B 43.38
Eagle Pharmaceuticals (EGRX) United States $0.738B 23.67
PetIQ (PETQ) United States $0.737B 20.93
MacroGenics (MGNX) United States $0.702B 0.00
Cerus (CERS) United States $0.685B 0.00
Lantheus Holdings (LNTH) United States $0.604B 18.68
Omeros (OMER) United States $0.569B 0.00
Owens & Minor (OMI) United States $0.550B 6.22
Insys Therapeutics (INSY) United States $0.531B 0.00
LeMaitre Vascular (LMAT) United States $0.510B 25.05
NanoString Technologies (NSTG) United States $0.478B 0.00
TG Therapeutics (TGTX) United States $0.429B 0.00
Evolus (EOLS) United States $0.373B 0.00
Quanterix (QTRX) United States $0.361B 0.00
Utah Medical Products (UTMD) United States $0.326B 21.11
Cytosorbents (CTSO) United States $0.287B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.254B 0.00
Rockwell Medical (RMTI) United States $0.230B 0.00
Surface Oncology (SURF) United States $0.218B 0.00
BioLife Solutions (BLFS) United States $0.197B 265.75
Bovie Medical (BVX) United States $0.189B 0.00
Chimerix (CMRX) United States $0.168B 0.00
Fonar (FONR) United States $0.141B 7.07
Conatus Pharmaceuticals (CNAT) United States $0.138B 0.00
Imprimis Pharmaceuticals (IMMY) United States $0.107B 0.00
Chembio Diagnostics (CEMI) United States $0.099B 0.00
United-Guardian (UG) United States $0.080B 16.85
Female Health (VERU) United States $0.077B 0.00
Oramed Pharmaceuticals (ORMP) Israel $0.071B 0.00
Trinity Biotech (TRIB) Ireland $0.068B 21.53
InfuSystems Holdings (INFU) United States $0.067B 0.00
CAS Medical Systems (CASM) United States $0.053B 0.00
Neurotrope (NTRP) United States $0.047B 0.00
ImmuCell (ICCC) United States $0.041B 0.00
Capricor Therapeutics (CAPR) United States $0.027B 0.00
Myomo (MYO) United States $0.024B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.018B 0.00
Valeritas Holdings (VLRX) United States $0.017B 0.00
Senestech (SNES) United States $0.017B 0.00
Cellectar Biosciences (CLRB) United States $0.011B 0.00
NeuroMetrix (NURO) United States $0.007B 0.00
Akers Biosciences Inc (AKER) United States $0.000B 0.00